Delivery Order SPE2DB20D1110-SPE2DB25FK00F

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM72A, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,341.58, is for the delivery of Lyrica 150 mg capsules. This is a firm fixed-price delivery order contract without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...
This federal contract award, with ID SPE2DB22D1017|SPE2DB24FF0FZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a pharmaceutical product, with a ceiling value of $3,587.94 and a completion date of December 26, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,911.60 firm fixed-price delivery order contract is for the provision of Lyrica 50 mg capsules. The contract has an ultimate completion date of February 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,571.40 firm-fixed-price delivery order is for 4,566,790,170 Lyrica 100 mg capsules in quantities of 90 per bottle. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
The U.S. Defense Logistics Agency (DLA) awarded a $2,768.15 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565602832 - Lyrica 100 mg capsules (90 count) and does not have a set-aside designation. This delivery order contract is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of Lyrica 150 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,075.80 and a completion date of September 18, 2024. The contract is not set aside for any specific program. AmerisourceBergen, a major pharmaceutical distributor, will supply the medication to support healthcare needs for military treatment facilities, veterans'...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 150mg capsules. The contract has a ceiling value of $2,939.05 and a period of performance through September 24, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lyrica 150 mg capsules. The contract, valued at $2,689.50, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 7, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery...
This federal contract award, with identification number SPE2DB22D2006|SPE2DB24FW3MJ, is a delivery order placed by the Defense Logistics Agency (DLA) Troop Support Medical with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which is not set-aside, is for the delivery of 4,565,802,758 units of the prescription drug Lyrica 150 mg capsule. The contract has a firm fixed price of $4,974.42 and an ultimate completion date of September 16, 2024. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,491.29, is a Firm Fixed Price Delivery Order for the supply of Lyrica 150 mg Capsules. The contract has an ultimate completion date of September 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB25FK00F
    Delivery Order

This federal contract award, with ID SPE2DB20D1110|SPE2DB25FK00F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,077.36, is for the delivery of Lyrica 150 mg capsules. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is March 11, 2025. The contract was not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/9/25, 9:42 AM